Immunogenicity and protective efficacy of a recombinant fusion protein containing the domain III of the dengue 1 envelope protein in non-human primates

被引:62
作者
Bernard, Lidice [1 ]
Izquierdo, Alienys [1 ]
Alvarez, Mayling [1 ]
Rosario, Delfina [1 ]
Prado, Irina [1 ]
Lopez, Carlos [2 ]
Martinez, Rafael [2 ]
Castro, Jorge [2 ]
Santana, Ernidalys [1 ]
Hermida, Lisset [2 ]
Guillen, Gerardo [2 ]
Guzman, Maria G. [1 ]
机构
[1] Pedro Kouri Trop Med Inst IPK, PAHO WHO Collaborating Ctr Study Dengue & Vector, Dept Virol, Havana, Cuba
[2] Ctr Genet Engn & Biotechnol, Havana 10600, Cuba
关键词
Denguel; 1; Domain III; Protection; Monkeys;
D O I
10.1016/j.antiviral.2008.06.005
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Recombinant fusion proteins containing the aa 286-426 of the dengue envelope protein fused to P64k protein from Neisseria meningitidis have been previously reported. Particularly, the immunogenicity and protective capacity of the dengue 2 recombinant protein was demonstrated in Macaca fascicularis monkeys. Here we evaluate the recombinant fusion protein containing the domain III of the dengue 1 envelope protein (PD10) in non-human primates (M. fascicularis and rhesus monkeys) and compare the effect of aluminum hydroxide and Freund adjuvant on the immunity induced. The PD10 protein emulsified in Freund adjuvant was highly immunogenic in M. fascicularis and rhesus monkeys. Following dengue 1 virus challenge, animals immunized with PD10 in Freund adjuvant were protected from viremia. However, monkeys receiving PD10 in aluminum hydroxide developed a poor antibody response and were not protected from viral challenge. These preliminary experiments are encouraging. Other formulations or vaccine schedules are being studied in an attempt to find regimens that enhance immunological protection. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:194 / 199
页数:6
相关论文
共 50 条
[1]  
Alvarez M, 2005, DENGUE B, V29, P1
[2]   Dengue hemorrhagic fever caused by sequential dengue 1-3 virus infections over a long time interval:: Havana epidemic, 2001-2002 [J].
Alvarez, Mayling ;
Rodriguez-Roche, Rosmari ;
Bernardo, Lidice ;
Vazquez, Susana ;
Morier, Luis ;
Gonzalez, Daniel ;
Castro, Osvaldo ;
Kouri, Gustavo ;
Halstead, Scott B. ;
Guzman, Maria G. .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2006, 75 (06) :1113-1117
[3]   Primary and secondary infections of Macaca fascicularis monkeys with Asian and American genotypes of dengue virus 2 [J].
Bernardo, Lidice ;
Izquierdo, Alienys ;
Prado, Irina ;
Rosario, Delfina ;
Alvarez, Mayling ;
Santana, Emidalys ;
Castro, Jorge ;
Martinez, Rafael ;
Rodriguez, Rosmari ;
Morier, Luis ;
Guillen, Gerardo ;
Guzman, Maria G. .
CLINICAL AND VACCINE IMMUNOLOGY, 2008, 15 (03) :439-446
[4]   Evaluation of immunity and protective efficacy of a dengue-3 premembrane and envelope DNA vaccine in Aotus nancymae monkeys [J].
Blair, PJ ;
Kochel, TJ ;
Raviprakash, K ;
Guevara, C ;
Salazar, M ;
Wu, SJ ;
Olson, JG ;
Porter, KR .
VACCINE, 2006, 24 (09) :1427-1432
[5]   The envelope glycoprotein domain III of dengue virus serotypes 1 and 2 inhibit virus entry [J].
Chin, J. F. L. ;
Chu, J. J. H. ;
Ng, M. L. .
MICROBES AND INFECTION, 2007, 9 (01) :1-6
[6]   Optimizing dengue diagnosis by RT-PCR in IgM-positive samples: comparison of whole blood, buffy-coat and serum as clinical samples [J].
De Paula, SO ;
da Fonseca, BAL .
JOURNAL OF VIROLOGICAL METHODS, 2002, 102 (1-2) :113-117
[7]   rDEN2/4Δ30(ME), a live attenuated chimeric dengue serotype 2 vaccine, is safe and highly immunogenic in healthy dengue-naive adults [J].
Durbin, Anna P. ;
McArthur, Julie H. ;
Marron, Jennifer A. ;
Blaney, Joseph E. ;
Thumar, Bhavin ;
Wanionek, Kimberli ;
Murphy, Brian R. ;
Whitehead, Stephen S. .
HUMAN VACCINES, 2006, 2 (06) :255-260
[8]   Phase I trial of 16 formulations of a tetravalent live-attenuated dengue vaccine [J].
Edelman, R ;
Wasserman, SS ;
Bodison, SA ;
Putnak, RJ ;
Eckels, KH ;
Tang, D ;
Kanesa-Thasan, N ;
Vaughn, DW ;
Innis, BL ;
Sun, W .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2003, 69 (06) :48-60
[9]   Relationship of preexisting dengue virus (DV) neutralizing antibody levels to viremia and severity of disease in a prospective cohort study of DV infection in Thailand [J].
Endy, TP ;
Nisalak, A ;
Chunsuttitwat, S ;
Vaughn, DW ;
Green, S ;
Ennis, FA ;
Rothman, AL ;
Libraty, DH .
JOURNAL OF INFECTIOUS DISEASES, 2004, 189 (06) :990-1000
[10]   COMMUNITY-BASED INTEGRATED CONTROL OF AEDES-AEGYPTI - A BRIEF OVERVIEW OF CURRENT PROGRAMS [J].
GUBLER, DJ ;
CLARK, GG .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1994, 50 (06) :50-60